These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 19659615

  • 1. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Osborne JS, Lappé DL, Bunch TJ.
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [Abstract] [Full Text] [Related]

  • 2. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Lappé DL, Bunch TJ.
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [Abstract] [Full Text] [Related]

  • 3. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K, Hirai T, Takashima S, Fukuda N, Ohara K, Sasahara E, Taguchi Y, Dougu N, Nozawa T, Tanaka K, Inoue H.
    Am J Cardiol; 2011 Mar 15; 107(6):912-6. PubMed ID: 21247518
    [Abstract] [Full Text] [Related]

  • 4. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation.
    Khumri TM, Idupulapati M, Rader VJ, Nayyar S, Stoner CN, Main ML.
    Am J Cardiol; 2007 Jun 15; 99(12):1733-6. PubMed ID: 17560884
    [Abstract] [Full Text] [Related]

  • 5. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 15; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 6. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Röther J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2010 Jul 15; 40(1):9-16. PubMed ID: 20385507
    [Abstract] [Full Text] [Related]

  • 7. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
    Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD.
    J Cardiovasc Electrophysiol; 2009 Sep 15; 20(9):988-93. PubMed ID: 19473299
    [Abstract] [Full Text] [Related]

  • 8. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B.
    Thromb Haemost; 2010 Apr 15; 103(4):833-40. PubMed ID: 20135077
    [Abstract] [Full Text] [Related]

  • 9. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
    Poli D, Antonucci E, Marcucci R, Fatini C, Alterini B, Mannini L, Falciani M, Abbate R, Gensini GF, Prisco D.
    Thromb Res; 2007 Apr 15; 121(3):347-52. PubMed ID: 17597186
    [Abstract] [Full Text] [Related]

  • 10. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.
    Heart Rhythm; 2015 Apr 15; 12(4):681-6. PubMed ID: 25546809
    [Abstract] [Full Text] [Related]

  • 11. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalán R, Aichner F, Steg PG, REACH Registry Investigators.
    Am Heart J; 2008 Nov 15; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P.
    Am J Cardiol; 2009 Nov 15; 104(10):1317-23. PubMed ID: 19892044
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
    Maehama T, Okura H, Imai K, Yamada R, Obase K, Saito K, Hayashida A, Neishi Y, Kawamoto T, Yoshida K.
    Am J Cardiol; 2010 Aug 15; 106(4):535-8. PubMed ID: 20691312
    [Abstract] [Full Text] [Related]

  • 14. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
    Guize L, Thomas F, Bean K, Benetos A, Pannier B.
    Bull Acad Natl Med; 2007 Aug 15; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):818-25. PubMed ID: 18294566
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):705-11. PubMed ID: 15734614
    [Abstract] [Full Text] [Related]

  • 17. Delayed detection of atrial fibrillation after ischemic stroke.
    Kamel H, Lees KR, Lyden PD, Teal PA, Shuaib A, Ali M, Johnston SC, Virtual International Stroke Trials Archive Investigators.
    J Stroke Cerebrovasc Dis; 2009 Mar 01; 18(6):453-7. PubMed ID: 19900647
    [Abstract] [Full Text] [Related]

  • 18. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
    Ruiz Ortiz M, Romo E, Mesa D, Delgado M, Anguita M, López Granados A, Castillo JC, Arizón JM, Suárez de Lezo J.
    Rev Esp Cardiol; 2008 Jan 01; 61(1):29-35. PubMed ID: 18221688
    [Abstract] [Full Text] [Related]

  • 19. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up.
    Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA.
    Circulation; 2008 Aug 26; 118(9):955-60. PubMed ID: 18697817
    [Abstract] [Full Text] [Related]

  • 20. [Impact of chronic atrial fibrillation on cardiovacular mortality].
    Scardi S, Mazzone C.
    Ital Heart J Suppl; 2000 Sep 26; 1(9):1117-22. PubMed ID: 11140280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.